PCK 3.23% 3.2¢ painchek ltd

Good news

  1. 2,341 Posts.
    lightbulb Created with Sketch. 21
    release: 6th September 2017
    ePAT signs core strategic agreement with Dementia Support Australia (DSA)

    • ePAT achieves first commercial agreement for clinical use of its TGA cleared pain assessment tool (ePAT App) with Dementia Support Australia (DSA).

    • DSA are government funded dementia support specialists with a nationwide team of 150 clinical consultants covering community, residential and acute settings.

    • DSA will use the ePAT App as a first line pain assessment tool for around 5,000 people with dementia in Australia each year.

    • This is a significant milestone in accelerating the commercialisation of the ePAT App in Australia and overseas.

      ePAT Technologies is delighted to announce it has signed its first commercial agreement for the clinical use of its pain assessment tool known as the ePAT App, with Dementia Support Australia (DSA).

      DSA provides nationwide consultant support and advice to carers of people with dementia who have behavioural and psychological symptoms of dementia that are impacting on their care. DSA is available to assist in community, residential and acute settings.

      The agreement involves deploying the ePAT App to DSA consultants for the purpose of assessing and monitoring pain. The ePAT App will be used to perform a baseline pain assessment during the consultant’s first visit to a patient and be used on subsequent visits to perform follow-up pain assessments so that the changes in the patients’ pain levels and associated behaviours are recorded. Typically DSA consultants will be involved with a particular patient for a 4-6 week period.

      Commencing in WA and SA from late September 2017 it is projected that the App will be fully embedded across DSA by Q1 2018. DSA’s 150 DSA consultants carry out approximately 5000 dementia patient assessments each year.

      The agreement covers the period up until 30 June 2019 although it may be terminated early after 31 March 2018 upon 3 months notice. Under the terms of the agreement the maximum fees payable to ePAT are $40,000 per annum.

      ePAT CEO, Philip Daffas, said he was delighted to have the opportunity to work with the Dementia Support Australia team to improve the quality of life for people with dementia in Australia. “This is a strategic relationship that has been developed over many months. We believe this is a unique combination of two Australian organisations working together to achieve a common goal in dementia
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.001(3.23%)
Mkt cap ! $52.39M
Open High Low Value Volume
3.1¢ 3.3¢ 3.1¢ $6.339K 202.4K

Buyers (Bids)

No. Vol. Price($)
2 87786 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 468791 2
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.